Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data
Go back to Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data| Exelixis, Inc. (NASDAQ: EXEL) | Delayed: 58.28 +1.06 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.22 | 52 Week High | $17.00 | |||
| Open | $57.65 | 52 Week Low | $3.55 | |||
| Day High | $59.09 | P/E | N/A | |||
| Day Low | $57.33 | EPS | $-1.33 | |||
| Volume | 885,420 | |||||

